首页 › 基金 › HighVista Strategies LLC › AMLX
HighVista Strategies LLC 对 AMLX 的持仓历史
AMYLYX PHARMACEUTICALS INC · 医疗保健
HighVista Strategies LLC 在 Q3 2026 的 13F 申报中披露持有 AMLX(AMYLYX PHARMACEUTICALS INC)153,515 股,市值约 US$4.5M,约占其申报组合的 1.17%,在其申报持仓中市值排名第 24 位。 HighVista Strategies LLC 最近 13 个申报季度中有 6 个季度披露了 AMLX 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
HighVista Strategies LLC 对 AMLX 的持仓演变
HighVista Strategies LLC 于 Q3 2023 首次披露 AMLX 持仓:26,349 股(约 US$482K)。 该持仓在 Q2 2026 达到峰值 386,080 股,市值约 US$6.9M。 在 6 次申报中,HighVista Strategies LLC 2 次增持、1 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 153,515 股、市值约 US$4.5M,环比减持 -232,565 股。。 持仓曾出现大幅变动:Q1 2026 增持约 47% (随后一个季度股价上涨 29%)、Q3 2026 减持约 60% (随后一个季度股价上涨 4%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 26.35K | $482.45K | 新进 |
| Q4 2023 | 26.35K | $387.86K | 持有 |
| Q4 2025 | 238.81K | $2.88M | 新进 |
| Q1 2026 | 352.08K | $4.89M | 增持 |
| Q2 2026 | 386.08K | $6.93M | 增持 |
| Q3 2026 | 153.51K | $4.47M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 AMLX 与 13F 数据
AMLX(AMYLYX PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 48 只申报持有 AMLX,申报仓位最大的包括:PERCEPTIVE ADVISORS LLC (US$149.7M), TCG Crossover Management, LLC (US$112.1M), Commodore Capital LP (US$101.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 AMLX 的基金
- PERCEPTIVE ADVISORS LLC 8.33M 股 · $149.69M · Q2 2026
- TCG Crossover Management, LLC 6.24M 股 · $112.14M · Q2 2026
- Commodore Capital LP 5.65M 股 · $101.47M · Q2 2026
- Saturn V Capital Management LP 4.62M 股 · $83.05M · Q2 2026
- Siren, L.L.C. 2.48M 股 · $72.19M · Q3 2026
- First Light Asset Management, LLC 3.02M 股 · $54.30M · Q2 2026
- Almitas Capital LLC 974.88K 股 · $17.51M · Q2 2026
- Boxer Capital Management, LLC 800.00K 股 · $14.37M · Q2 2026
- GREAT POINT PARTNERS LLC 700.00K 股 · $12.57M · Q2 2026
- Parkman Healthcare Partners LLC 398.78K 股 · $7.16M · Q2 2026
- STEMPOINT CAPITAL LP 384.30K 股 · $6.90M · Q2 2026
更多关于 HighVista Strategies LLC
常见问题
How long has HighVista Strategies LLC held AMLX?
HighVista Strategies LLC has disclosed AMLX holdings in 6 of the last 13 reported quarters, going back to Q3 2023.
What is HighVista Strategies LLC's current position in AMLX?
As of Q3 2026, HighVista Strategies LLC holds 153.51K shares of AMLX (AMYLYX PHARMACEUTICALS INC), valued at $4.47M, representing 1.17% of its reported portfolio and ranking #24.
Has HighVista Strategies LLC been buying or selling AMLX?
In the latest 13F filing (Q3 2026), HighVista Strategies LLC reduced its position in AMLX. The position peaked in Q2 2026 at 386.08K shares.
Which other funds hold AMLX?
Other major institutional holders of AMLX include PERCEPTIVE ADVISORS LLC, TCG Crossover Management, LLC, Commodore Capital LP, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.